Grifols says trial shows positive effects in slowing Alzheimer'sAlbumin, Alzheimer’s disease, Clinical Trials, Immunoglobulins, Plasma, R&D, Spain, United StatesSpain’s Grifols said the latest results from a clinical trial of the company’s Alzheimer’s treatment show positive effects by achieving a reduction of the disease’s progression in patients with mild and moderate conditions. Read more December 6, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-12-06 15:14:532019-12-06 15:14:53Grifols says trial shows positive effects in slowing Alzheimer's